Becky Parks

1.9k citations

31 papers · 1.2k indexed · h-index 17

Impact in

Pathology and Forensic Medicine top 2%
- Multiple Sclerosis Research Studies
Neurology top 5%
- Peripheral Neuropathies and Disorders
- Neuroinflammation and Neurodegeneration Mechanisms

Papers in

Pathology and Forensic Medicine 20
- Multiple Sclerosis Research Studies 18
- Spine and Intervertebral Disc Pathology 2
Neurology 13
- Peripheral Neuropathies and Disorders 11
- Amyotrophic Lateral Sclerosis Research 2

Co-authors: Anne H. Cross Robert T. Naismith Laura Piccio Kathryn Trinkaus Jeri‐Anne Lyons Enrique Álvarez Robyn S. Klein Eric C. Klawiter
Journals: Neurology (9 papers)Multiple Sclerosis Journal (3 papers)Neurology and Therapy (2 papers)Therapeutic Advances in Neurological Disorders (2 papers)Journal of Neurology Neurosurgery & Psychiatry (1 paper)
Partner nations: United States Germany Switzerland

In The Last Decade

Becky Parks

30 papers receiving 1.1k citations

Peers

Countries citing papers authored by Becky Parks

Since Specialization

Citations

This map shows the geographic impact of Becky Parks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Becky Parks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Becky Parks more than expected).

Fields of papers citing papers by Becky Parks

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Becky Parks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Becky Parks. The network helps show where Becky Parks may publish in the future.

Co-authors

The 25 scholars most cited alongside Becky Parks, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Becky Parks Line = papers co-authored together Becky Parks links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Immediate and sustained terminal complement inhibition with ravulizumab in patients with anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder Frontiers in Neurology ·Stephan Ortiz, Sean J. Pittock, Achim Berthele, Michael Levy, Ichiro Nakashima, Celia Oreja‐Guevara, Kerstin Allen, Yasmin Mashhoon, Becky Parks, Ho Jin Kim	2024	2
2	Incidence of Relapses After Meningococcal Vaccination in Clinical Trials of Eculizumab and Ravulizumab in Anti-Aquaporin-4 Antibody-Positive (AQP4-Ab+) Neuromyelitis Optica Spectrum Disorder (NMOSD) Neurology ·Sami Fam, Kerstin Allen, Becky Parks	2024	1
3	Efficacy and Safety of Ravulizumab in Adults With Anti-Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder (AQP4+ NMOSD): Interim Analysis From the Ongoing Phase 3 CHAMPION-NMOSD Trial (S32.003) Neurology ·Sean J. Pittock, Michael Barnett, Jeffrey L. Bennett, Achim Berthele, J. de Sèze, Michaël Levy, Ichiro Nakashima, Celia Oreja‐Guevara, Jacqueline Palace, Friedemann Paul, Carlo Pozzilli, Yasmin Mashhoon, Kerstin Allen, Becky Parks, Ho Jin Kim	2024	1
4	Clinical and real-world pharmacovigilance data of meningococcal infections in eculizumab- or ravulizumab-treated patients Journal of the Neurological Sciences ·Sami Fam, Brian Werneburg, Shirali Pandya, Becky Parks, Yasmin Mashhoon, Kerstin Allen, Glen Frick, Katie Beasley, Alexander Zodiatis, Vidya Chitikireddi, Hua Zhang, Guido Sabatella, Arshad Mujeebuddin	2023	3
5	Safety and efficacy of daclizumab beta in patients with relapsing multiple sclerosis in a 5-year open-label study (EXTEND): final results following early termination Therapeutic Advances in Neurological Disorders ·Ludwig Kappos, Stanley Cohan, Douglas L. Arnold, Randy Robinson, Joan Holman, Sami Fam, Becky Parks, Shan Xiao, Wanda Castro-Borrero	2021	4
6	Real-World Safety and Effectiveness of Dimethyl Fumarate in Black or African American Patients with Multiple Sclerosis: 3-Year Results from ESTEEM Neurology and Therapy ·Mitzi Williams, Lilyana Amezcua, Annette Okai, Darin T. Okuda, Stanley Cohan, Ray Su, Becky Parks, Jason P. Mendoza, James B. Lewin, Cynthia C. Jones	2020	21
7	An International Registry Tracking Pregnancy Outcomes in Women Treated with Dimethyl Fumarate (1003) Neurology ·Kerstin Hellwig, David Rog, Christopher McGuigan, Kun Chen, Becky Parks, Cynthia C. Jones	2020	4
8	Immunomodulatory Effects of DMF Treatment on the Peripheral Lymphocyte Compartment: A Focus on Older MS Patients (478) Neurology ·Fabrizio Giuliani, Erin E. Longbrake, Yang Mao‐Draayer, Derrick Robertson, Amit Bar‐Or, Oksana Mokliatchouk, Eris Bame, Diana Xing, Becky Parks, Chongshu Chen, Catherine Miller	2020	1
9	Safety and Effectiveness of Dimethyl Fumarate Maintained Over 4 Years in Multiple Sclerosis Patients Treated in Routine Medical Practice (1346) Neurology ·Krupa Pandey, Kathryn Giles, Konstantin Balashov, Richard Macdonell, Jörg Windsheimer, Oksana Mokliatchouk, Becky Parks, Filipe Branco, Cynthia C. Jones	2020	1
10	Predicting optimal response to B-cell depletion with rituximab in multiple sclerosis using CXCL13 index, magnetic resonance imaging and clinical measures Multiple Sclerosis Journal - Experimental Translational and Clinical ·Enrique Álvarez, Laura Piccio, Robert Mikesell, Kathryn Trinkaus, Becky Parks, Robert T. Naismith, Anne H. Cross	2015	29
11	Monoclonal Antibodies as Disease Modifying Therapy in Multiple Sclerosis Current Neurology and Neuroscience Reports ·Erin E. Longbrake, Becky Parks, Anne H. Cross	2013	5
12	CXCL13 is a biomarker of inflammation in multiple sclerosis, neuromyelitis optica, and other neurological conditions Multiple Sclerosis Journal ·Enrique Álvarez, Laura Piccio, Robert Mikesell, Eric C. Klawiter, Becky Parks, Robert T. Naismith, Anne H. Cross	2013	96
13	Spinal Cord Ring Enhancement in Multiple Sclerosis Archives of Neurology ·Eric C. Klawiter, Tammie L.S. Benzinger, Abhik Roy, Robert T. Naismith, Becky Parks, Anne H. Cross	2010	27
14	Changes in B- and T-Lymphocyte and Chemokine Levels With Rituximab Treatment in Multiple Sclerosis Archives of Neurology ·Laura Piccio, Robert T. Naismith, Kathryn Trinkaus, Robyn S. Klein, Becky Parks, Jeri‐Anne Lyons, Anne H. Cross	2010	206
15	Rituximab add-on therapy for breakthrough relapsing multiple sclerosis Neurology ·Robert T. Naismith, Laura Piccio, Jeri‐Anne Lyons, J. Lauber, Nhial T. Tutlam, Becky Parks, Kathryn Trinkaus, Song Sheng, Anne H. Cross	2010	169
16	Cerebrospinal fluid progranulin levels in patients with different multiple sclerosis subtypes Neuroscience Letters ·Milena De Riz, Daniela Galimberti, Chiara Fenoglio, Laura Piccio, D. Scalabrini, E. Venturelli, Anna M. Pietroboni, Mirko Piola, Robert T. Naismith, Becky Parks, Giorgio Fumagalli, Nereo Bresolin, Anne H. Cross, Elio Scarpini	2009	18
17	A role for functional classification in the early identification of prognostic factors in ALS Amyotrophic Lateral Sclerosis ·Amy C. Rauchway, Kitti Kaiboriboon, Sachin Bansal, Kongkiat Kulkantrakorn, Xiaoyan Guo, Becky Parks, Ghazala Hayat	2007	4
18	Spouses of Persian Gulf War I Veterans: Medical Evaluation of a U.S. Cohort Military Medicine ·Seth A. Eisen, Joel Karlinsky, Leila W. Jackson, Melvin Blanchard, Han K. Kang, Frances M. Murphy, Renee Alpern, Domenic J. Reda, Rosemary Toomey, Michael J. Battistone, Becky Parks, Nancy G. Klimas, Hon S. Pak, Joyce Hunter, Michael J. Lyons, William G. Henderson, (unknown)	2006	5
19	Nerve root hypertrophy as the cause of lumbar stenosis in chronic inflammatory demyelinating polyradiculoneuropathy Muscle & Nerve ·Jonathan Goldstein, Becky Parks, Peter L. Mayer, Jung Ho Kim, Gordon Sze, Robert G. Miller	1996	29
20	Postoperative peripheral neuropathies. PubMed ·Becky Parks	1973	112

About Becky Parks

Becky Parks is a scholar working on Pathology and Forensic Medicine, Neurology, Developmental Biology, Immunology and Rheumatology, having authored 31 papers that have together received 1.2k indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (18 papers), Peripheral Neuropathies and Disorders (11 papers), Immunotherapy and Immune Responses (5 papers), Polyomavirus and related diseases (4 papers), Systemic Lupus Erythematosus Research (3 papers), Spine and Intervertebral Disc Pathology (2 papers), Protein Tyrosine Phosphatases (2 papers) and Amyotrophic Lateral Sclerosis Research (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (680 citations), Neurology (348 citations), Immunology (319 citations), Neurology (94 citations) and Rheumatology (167 citations). Becky Parks has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Anne H. Cross, Robert T. Naismith, Laura Piccio, Kathryn Trinkaus, Jeri‐Anne Lyons, Enrique Álvarez, Robyn S. Klein, Eric C. Klawiter, Erin E. Longbrake and Song Sheng. Their work appears in journals such as Neurology, Multiple Sclerosis Journal, Neurology and Therapy, Therapeutic Advances in Neurological Disorders and Journal of Neurology Neurosurgery & Psychiatry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact